$MGTX 3 SEC Filings

Filed On	Filing
24 Sep 2026	Form 3: Sebulsky Alan, Director Holds 34,500 shares of Ordinary Shares
14 May 2026	Form 3: Fleck Penny Renee, CHIEF DEVELOPMENT OFFICER No securities owned
13 Aug 2024	Form 3: Sanofi, 10% owner Holds 11,500,000 shares of Ordinary Shares ($0.00003881 par value per share)
18 Sep 2023	Form 3: Johnson & Johnson Innovation - JJDC, Inc., 10% owner Holds 6,641,064 shares of Ordinary Shares
14 Nov 2022	Form 3: Johnson & Johnson, 10% owner and 1 other Holds 6,641,064 shares of Ordinary Shares
27 Apr 2022	Form 3: Yu Debra, Director No securities owned
05 Aug 2020	Form 3: Zeldin Robert K, Chief Medical Officer No securities owned
17 Jun 2020	Form 3: Wollin Robert J, General Counsel and Secretary
13 May 2019	Form 3: Seligman Nicole, Director No securities owned
02 Apr 2019	Form 3: Gottlieb Bruce, General Counsel No securities owned
21 Feb 2019	Form 3: Indyk Martin, Director No securities owned
04 Oct 2018	Form 3: Breedis Katherine, Chief Financial Officer No securities owned
11 Jun 2018	Form 3: Hukkelhoven Ellen, Director Holds 0 shares of Ordinary shares
08 Jun 2018	Form 3: Perceptive Advisors Llc, Director and 2 others Holds 3,320,065 shares of Ordinary shares
08 Jun 2018	Form 3: Marcus Joel S, Director Holds 1,649,393 shares of Ordinary Shares
08 Jun 2018	Form 3: Shenk Thomas E, Director Holds 170,809 shares of Ordinary Shares
08 Jun 2018	Form 3: Moss Gregory S., Director Holds 41,285 shares of Ordinary Shares
08 Jun 2018	Form 3: Harris Keith R., Director
08 Jun 2018	Form 3: Mendoza Neil, Director Holds 12,883 shares of Ordinary Shares
08 Jun 2018	Form 3: Naylor Stuart, Director Holds 498,017 shares of Ordinary Shares

Comments